Judge Lifts Injunction On Drug Maker

Law360, New York (March 7, 2007, 12:00 AM EST) -- The judge overseeing Dusa Pharmaceuticals Inc.’s patent infringement suit against River’s Edge Pharmaceuticals LLC has lifted a preliminary injunction that barred a competitor from entering the market for Dusa acne treatment Nicomide.

On Wednesday, U.S. District Judge Stanley R. Chesler filed an order dissolving the injunction and granting a motion by River’s Edge that called the validity of the patent asserted by Dusa into question.

At issue in the suit is U.S. Patent Number 6,979,468, which covers an oral treatment of inflammatory skin disorders comprising nicotinamide...
To view the full article, register now.